You searched for "adults"

794 results found

New sites needed for STARFISH trial

The STARFISH Trial is aiming to recruit 525 participants with sudden hearing loss from 75 ENT departments treating idiopathic sudden sensorineural hearing loss (ISSNHL).

Hearing pioneer Gerard O'Donoghue retires

The Nottingham Auditory Implant Programme (NAIP) has announced the retirement of Professor Gerard O’Donoghue, Consultant Neuro-Otologist at Queen’s Medical Centre, Nottingham. A pioneer in the field of hearing restoration, Gerry’s career has been defined by his groundbreaking work in cochlear implantation.

Top ten research priorities for dementia and hearing loss

Researchers from Nottingham working with Alzheimer’s Research UK and RNID (the Royal National Institute for Deaf People) asked people living with these conditions, as well as their families and clinicians, what future research would have the biggest impact for them.

Hong Kong Auditory Science Meeting 2025

Yuan Chen, Assistant Professor in the Department of Special Education and Counselling, The Education University of Hong Kong.Organised by the Clinical Hearing Sciences (CHearS) Laboratory and supported by the University Grants Committee and the Faculty of Education at the University...

Audiology Answers for Otolaryngologists

Audiology Answers for Otolaryngologists aims to provide a grounding in audiology for otolaryngology residents and other professionals allied to audiology, who would otherwise have limited exposure to clinical audiology. It is written by senior audiologists at Washington University School of...

Acute peripheral vestibulopathy: is it really neuritis?

The pathophysiology of acute vestibular dysfunction has been debated for decades. By seeking to clarify the underlying aetiology, this study muddies the waters further by advocating systemic and intratympanic steroids as first line treatment if the aetiology is uncertain. The...

CRSwNP, another monoclonal antibody

Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...

Can amplification preserve auditory function?

Hearing loss is a noted modifiable risk factor for dementia, and is also associated with depression, decreased quality of life and isolation. Hearing aids are the main intervention for presbycusis and a 2017 Cochrane Review showed that they have a...

Persistent imbalance after traumatic brain injury is central in origin

Several residual symptoms, including dizziness and imbalance, can follow traumatic brain injury, no matter how mild. This study focused on the mechanisms, peripheral and central, underlying the complaint of persistent imbalance in patients with chronic mild traumatic brain injury (mTBI)....

Subtypes of vestibular migraine

The authors argue that the current Barany criteria (ICVD) for vestibular migraine (definite and probable – dVM and pVM) are too restrictive. For instance, whereas a category of chronic migraine with or without aura is recognised in ICHD-3, ‘chronic VM’...

Ethnic inequalities in hearing aid use

Recent events, including the COVID-19 pandemic, have once again highlighted health inequalities experienced by people from ethnic minority backgrounds. Our Editors’ Choice paper shows that there are inequalities in hearing aid use and includes the stark finding that ethnicity is...

Combined use of a hearing aid and a cochlear implant: a case study

When multi-channel cochlear implants (CIs) were first introduced in the 1980s, their use was restricted to people who derived no benefit from conventional amplification. Over the past three decades, however, the criteria for CIs has been relaxed considerably, and it...